Showing 206 news articles about Side effects

Filters Content type: Editors' picks Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

Weight gain & lipodystrophy

Weight gain, raised blood pressure risk seen for HIV patients switching to dolutegravir

Editor's pick
Medical Xpress
22 March 2023
PrEP

CROI 2023: Bone density profiles for long-acting cabotegravir vs TDF/FTC oral PrEP in young people

Editor's pick
i-Base
9 March 2023
Cardiovascular disease

HIV drug may be linked to increased risk of hypertension

Editor's pick
Medical Xpress
22 February 2023
Side effects

Researchers identify how HIV/hepatitis drug harms the kidneys

Editor's pick
Medical Xpress
18 January 2023
Weight gain & lipodystrophy

Obesity Risk Higher With DTG Than Other Regimens in 3 Big African Trials

Editor's pick
NATAP
1 November 2022
Side effects

Go Slow Before Switching HIV Meds Due to Metabolic Effects

Editor's pick
Infectious Disease Special Edition
14 September 2022
HIV treatment

Mozambique: Half a Million HIV-Positive People Abandon Anti-Retroviral Treatment

Editor's pick
AllAfrica
29 July 2022
Changing treatment

‘The Devil You Know’: Many People Over 50 Are Taking Outdated ART, Despite Side Effects

Editor's pick
TheBodyPro
27 April 2022
PrEP science

Kidney Toxicity Rare With Daily or On-Demand (As-Needed) PrEP

Editor's pick
NATAP
31 October 2021
PrEP science

Truvada or Descovy for PrEP? Your Lab Work May Tell You

Editor's pick
POZ
8 September 2021
Pharmaceutical industry

Negative innovation: when patents are bad for patients

Editor's pick
Nature
12 August 2021
New & experimental HIV treatments

HIV: Could Another Two-Drug Regimen Be on the Horizon?

Editor's pick
Medscape (requires free registration)
21 July 2021
HIV treatment in pregnancy

Antiretrovirals for HIV Don’t Raise Birth Defect Risk

Editor's pick
POZ
27 March 2021
Treatment guidelines

1.3m switched to new ARV, but weight gain is a concern

Editor's pick
Spotlight
25 August 2020
Pharmaceutical industry

U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival

Editor's pick
FiercePharma
15 July 2020
Neurological & cognitive problems

Neuropathy and Neuropathic Pain Still on Rise in HIV+, But No Clear Links to ART

Editor's pick
NATAP
10 July 2020
Side effects

Can This Medicine From a Rainforest Plant Stop Chronic Diarrhea in Folks With HIV?

Editor's pick
TheBody
1 May 2020
PrEP science

Uptick in Statin Use After Descovy in HIV PrEP

Editor's pick
Medscape (requires free registration)
9 March 2020
Treatment guidelines

South Africa: Health Department’s dolutegravir plans hit stumbling block

Editor's pick
MedicalBrief
2 March 2020
Weight gain & lipodystrophy

TreatmentUpdate: weight gain

Editor's pick
CATIE
28 January 2020
Weight gain & lipodystrophy

What we know about Descovy’s impact on weight & cholesterol

Editor's pick
San Francisco AIDS Foundation
9 January 2020
Bad science & bogus treatments

Facebook disables some misleading ads on HIV prevention drugs, responding to growing outcry

Editor's pick
Washington Post
2 January 2020
PrEP science

Facebook ads push misinformation about HIV prevention drugs, LGBT activists say, ‘harming public health’

Editor's pick
Washington Post
10 December 2019
Pharmaceutical industry

Gilead delayed safer HIV drug to extend monopoly profits, advocates allege

Editor's pick
San Francisco Chronicle
6 December 2019